Evidence map›Paper›PMID 40295841›Full record

ArticleNpj viruses2024

Molecular epidemiology of the HIV-1 epidemic in Fiji.

Atlesh Sudhakar, Donald Wilson, Rachel Devi, Dashika Anshu Balak, Jenni Singh, Kesaia Tuidraki, Lavenia Gaunavinaka, Waisale Turuva, Taina Naivalu, Blair Lawley and 4 more

Abstract read
In one paragraph

Article in Npj viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Atlesh SudhakarFiji Institute of Pacific Health Research, Fiji National University, Suva, Fiji.
Donald WilsonFiji Institute of Pacific Health Research, Fiji National University, Suva, Fiji.
Rachel DeviMinistry of Health, Suva, Fiji.
Dashika Anshu BalakSexual and Reproductive Health Clinic (Central Eastern Division), Suva, Fiji.
Jenni SinghReproductive Health Clinic, Suva Hub, Fiji.
Kesaia TuidrakiMedical Services Pacific (MSP), Suva, Fiji.
Lavenia GaunavinakaReproductive Health Clinic, Western Hub, Suva, Fiji.
Waisale TuruvaReproductive Health Clinic, Northern Hub, Suva, Fiji.
Taina NaivaluFiji Institute of Pacific Health Research, Fiji National University, Suva, Fiji.
Blair LawleyDepartment of Microbiology and Immunology, University of Otago, Dunedin, 9016, New Zealand.
John H TayDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
Francesca Di GiallonardoThe Kirby Institute, University of New South Wales, Sydney, 2052, NSW, Australia.
Sebastian DucheneDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
Jemma L GeogheganDepartment of Microbiology and Immunology, University of Otago, Dunedin, 9016, New Zealand. jemma.geoghegan@otago.ac.nz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Very little is known about the HIV-1 epidemic in Fiji, nor the wider South Pacific region more generally, yet new reported HIV-1 infections are on the rise. As of 2023, there are an estimated 2000 cases of HIV-1 in Fiji with heterosexual contact the primary route of transmission. In this study, we used a molecular epidemiological approach to better understand the genetic diversity of the HIV-1 epidemic in Fiji and reveal patterns of viral transmission. Between 2020 and 2021, venous blood samples were collected from people who had previously been diagnosed with HIV-1. We generated molecular data from 53 infections, representing ~2-3% of reported cases, to identify HIV-1 subtypes and determine the outbreak's trajectory. Among the 53 HIV-1 cases, we used Bayesian inference to estimate six separate introductions with at least two of these introductions leading to sustained transmission forming large, nation-wide clusters of HIV-1 subtype C. We found that since the introduction of public health interventions circa 2014, the effective reproductive number, R

Identifiers

PMID40295841
PMCPMC11721668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.